Form 191 Core Alcohol and Drug Survey For use by two- and four-year institutions Core Institute Student Health Programs

First Page		Document Content
Date: 2016-07-30 02:54:16 Neurochemistry Nervous system Neuropsychology Drug control law Euphoriants Drug culture Designer drug Prohibition of drugs Inhalant MDMA Hallucinogen Recreational drug use		Form 191 Core Alcohol and Drug Survey For use by two- and four-year institutions Core Institute Student Health Programs Add to Reading List Source URL: core.siu.edu Download Document from Source Website File Size: 75,44 KB Share Document on Facebook

	FLUBROMAZEPAM Stephanie Hopkins, California Department of Justice, 4949 Broadway, Room F-249, Sacramento CA, Manufacturer: A “designer” drug. First described in 1962 by Sternbach ( DocID: 1u7eJ - View Document
	FLUBROMAZEPAM Stephanie Hopkins, California Department of Justice, 4949 Broadway, Room F-249, Sacramento CA, Manufacturer: A “designer” drug. First described in 1962 by Sternbach ( DocID: 1u2MR - View Document
	Ekctmchimica Acta,Vol.39.No. 4.ppCopyri&tt Q 1994 Elsevier Scicna Ltd. Printed inGreatBritainAU rights mewed DocID: 1sNHy - View Document
	LETTER 555 A Simple Protocol for Direct Reductive Amination of Aldehydes and Ketones Using Potassium Formate and Catalytic Palladium Acetate DocID: 1stBf - View Document
	TETRAHEDRON Pergamon Tetrahedron±5674 A modi®ed palladium catalysed reductive amination procedure DocID: 1rDwT - View Document